New Data for NUBEQA® Build on Safety and Efficacy Results Across Subgroups of Patients with Metastatic Hormone-Sensitive ...

Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...

Christian Edouard-Betsy was at work when his doctor called and asked him to meet immediately to discuss the results of a ...

Nubeqa plus ADT improved rPFS in mHSPC regardless of disease volume, reducing the risk of radiological progression or death ...

Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...

The addition of 177Lu-PSMA-617 to enzalutamide significantly improved overall survival and QOL in patients with metastatic ...

With delays in biomarker testing and treatment for metastatic castration-resistant prostate cancer, continued education is ...

Today, the National Sleep Foundation (NSF) announced Sleep Awareness Week® 2025 will take place from March 9-15. Sleep Awareness Week, now in its 27th year, is the NSF's annual campaign emphasizing ...

With a new treatment for prostate cancer in play, men with more aggressive forms of prostate cancer may have a more positive ...

ZoaDx, a newly launched clinical research organization, is dedicated to advancing animal health and agricultural sustainability through expert clinical research, tailored regulatory solutions, and ...